Helix BioPharma Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
103.49 M |
Public Float |
- |
Helix BioPharma Corp. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD0.07 |
Market Cap |
CAD27.81 M |
Shares Outstanding |
111.23 M |
Public Float |
95.67 M |
Address |
9120 Leslie Street Richmond Hill Ontario L4B 3J9 Canada |
Employees | - |
Website | http://www.helixbiopharma.com |
Updated | 07/08/2019 |
Helix BioPharma Corp. is a clinical stage biopharmaceutical company, which develops products for the treatment and prevention of cancer. It focuses on the development and commercialization of innovative medicines in the areas of cancer prevention and treatment. Its product portfolio includes Topical Interferon Alpha-2b DOS47, Orthovisc, Monovisc, Normacol, Car-T, Imunovir and Klean-Prep. |